chr19-39706658-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020129.3(LGALS14):c.77C>T(p.Pro26Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,613,258 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020129.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LGALS14 | ENST00000392052.8 | c.77C>T | p.Pro26Leu | missense_variant | 2/4 | 1 | NM_020129.3 | ENSP00000375905.2 | ||
LGALS14 | ENST00000360675.7 | c.164C>T | p.Pro55Leu | missense_variant | 3/5 | 3 | ENSP00000353893.2 | |||
LGALS14 | ENST00000601802.1 | c.42-520C>T | intron_variant | 5 | ENSP00000471660.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152140Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000677 AC: 17AN: 251132Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135676
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461118Hom.: 0 Cov.: 30 AF XY: 0.0000399 AC XY: 29AN XY: 726908
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.164C>T (p.P55L) alteration is located in exon 3 (coding exon 2) of the LGALS14 gene. This alteration results from a C to T substitution at nucleotide position 164, causing the proline (P) at amino acid position 55 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at